The results indicated that G6PD changed cell cycle dynamics, facilitated cell proliferation, promoted migration in vitro, and enhanced ccRCC tumor growth in vivo, probably by upregulating Cyclin E1 and MMP9. Here, CCNE1 is linked to nonpapillary renal cell carcinoma.